{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:08:41Z","timestamp":1789031321993,"version":"build-2803163510"},"reference-count":80,"publisher":"China Science Publishing & Media Ltd.","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2026,9,1]]},"DOI":"10.3724\/abbs.2026152","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T05:58:58Z","timestamp":1786946338000},"update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":0,"title":["Multicellular human cardiac organoids with real-time calcium imaging enable functional modeling of heart failure and myocardial infarction"],"prefix":"10.3724","author":[{"given":"Vishnu Goutham","family":"Kota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shachin Velur","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin Love","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samriddhi","family":"Senthilkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazal Esfahani","family":"Maragheh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwa Liang","family":"Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanry","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","volume":"80","author":"Vaduganathan M","year":"2022","unstructured":"Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk. J Am Coll Cardiol, 2022, 80: 2361-2371.","journal-title":"J Am Coll Cardiol"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.15420\/cfr.2023.05","volume":"9","author":"Shahim B","year":"2023","unstructured":"Shahim B, Kapelios CJ, Savarese G, Lund LH. Global public health burden of heart failure: an updated review. Card Fail Rev, 2023, 9:","journal-title":"Card Fail Rev"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12872-023-03231-w","volume":"23","author":"Salari N","year":"2023","unstructured":"Salari N, Morddarvanjoghi F, Abdolmaleki A, Rasoulpoor S, Khaleghi AA, Hezarkhani LA, Shohaimi S. The global prevalence of myocardial infarction: a systematic review and meta-analysis. BMC Cardiovasc Disord, 2023, 23:","journal-title":"BMC Cardiovasc Disord"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s44222-023-00063-3","volume":"1","author":"Loewa A","year":"2023","unstructured":"Loewa A, Feng JJ, Hedtrich S. Human disease models in drug development. Nat Rev Bioeng, 2023, 1: 545-559.","journal-title":"Nat Rev Bioeng"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"673683","DOI":"10.3389\/fbioe.2021.673683","volume":"9","author":"Shin HS","year":"2021","unstructured":"Shin HS, Shin HH, Shudo Y. Current status and limitations of myocardial infarction large animal models in cardiovascular translational research. Front Bioeng Biotechnol, 2021, 9:","journal-title":"Front Bioeng Biotechnol"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1002\/ejhf.2631","volume":"24","author":"Mohr E","year":"2022","unstructured":"Mohr E, Thum T, B\u00e4r C. Accelerating cardiovascular research: recent advances in translational 2D and 3D heart models. Eur J Heart Fail, 2022, 24: 1778-1791.","journal-title":"Eur J Heart Fail"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"e38147","DOI":"10.1371\/journal.pone.0038147","volume":"7","author":"Soares CP","year":"2012","unstructured":"Soares CP, Midlej V, Oliveira MEW, Benchimol M, Costa ML, Mermelstein C, Cordes N. 2D and 3D-organized cardiac cells shows differences in cellular morphology, adhesion junctions, presence of myofibrils and protein expression. PLoS ONE, 2012, 7:","journal-title":"PLoS ONE"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"910","DOI":"10.5114\/aoms.2016.63743","volume":"14","author":"Kapa\u0142czy\u0144ska M","year":"2016","unstructured":"Kapa\u0142czy\u0144ska M, Kolenda T, Przyby\u0142a W, Zaj\u0105czkowska M, Teresiak A, Filas V, Ibbs M. 2D and 3D cell cultures\u2014a comparison of different types of cancer cell cultures. aoms, 2016, 14:","journal-title":"aoms"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"117784","DOI":"10.1016\/j.lfs.2020.117784","volume":"254","author":"Foglietta F","year":"2020","unstructured":"Foglietta F, Canaparo R, Muccioli G, Terreno E, Serpe L. Methodological aspects and pharmacological applications of three-dimensional cancer cell cultures and organoids. Life Sci, 2020, 254:","journal-title":"Life Sci"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"882","DOI":"10.3390\/cells14120882","volume":"14","author":"Cao T","year":"2025","unstructured":"Cao T, Warren CR.  From 2D myotube cultures to 3D engineered skeletal muscle constructs: a comprehensive review of in vitro skeletal muscle models and disease modeling applications . Cells, 2025, 14:","journal-title":"Cells"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1021\/acsbiomaterials.6b00662","volume":"3","author":"Fine B","year":"2017","unstructured":"Fine B, Vunjak-Novakovic G. Shortcomings of animal models and the rise of engineered human cardiac tissue. ACS BioMater Sci Eng, 2017, 3: 1884-1897.","journal-title":"ACS BioMater Sci Eng"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42826-021-00102-3","volume":"37","author":"Joukar S","year":"2021","unstructured":"Joukar S. A comparative review on heart ion channels, action potentials and electrocardiogram in rodents and human: extrapolation of experimental insights to clinic. Lab Anim Res, 2021, 37: 1-5.","journal-title":"Lab Anim Res"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.20935\/acadneurosci8190","volume":"2","author":"Trevi\u00f1o M","year":"2026","unstructured":"Trevi\u00f1o M, Arias-Carri\u00f3n O. Structural shifts and constraints in animal-based neuroscience. Academia Neurosci Brain Res, 2026, 2: 1-7.","journal-title":"Academia Neurosci Brain Res"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jot.2025.08.005","volume":"55","author":"Gao Q","year":"2025","unstructured":"Gao Q, Chow SKH, Shinohara I, Murayama M, Susuki Y, Morita M, Ma C. Can alternatives to animal testing yield useful information regarding biological mechanisms and drug discovery?. J Orthopaedic Translation, 2025, 55: 132-145.","journal-title":"J Orthopaedic Translation"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"1188905","DOI":"10.3389\/fcell.2023.1188905","volume":"11","author":"Xu Z","year":"2023","unstructured":"Xu Z, Yang J, Xin X, Liu C, Li L, Mei X, Li M. Merits and challenges of iPSC-derived organoids for clinical applications. Front Cell Dev Biol, 2023, 11:","journal-title":"Front Cell Dev Biol"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.stem.2019.05.005","volume":"24","author":"Brassard JA","year":"2019","unstructured":"Brassard JA, Lutolf MP. Engineering stem cell self-organization to build better organoids. Cell Stem Cell, 2019, 24: 860-876.","journal-title":"Cell Stem Cell"},{"key":"CITATION17","doi-asserted-by":"crossref","unstructured":"Pazzin DB, Previato TTR, Budelon Gon\u00e7alves JI, Zanirati G, Xavier FAC, da Costa JC, Marinowic DR. Induced pluripotent stem cells and organoids in advancing neuropathology research and therapies.  Cells  2024, 13: 745 .","DOI":"10.3390\/cells13090745"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.stem.2020.02.011","volume":"26","author":"Sharma A","year":"2020","unstructured":"Sharma A, Sances S, Workman MJ, Svendsen CN. Multi-lineage human iPSC-derived platforms for disease modeling and drug discovery. Cell Stem Cell, 2020, 26: 309-329.","journal-title":"Cell Stem Cell"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"113611","DOI":"10.1016\/j.isci.2025.113611","volume":"28","author":"Cao X","year":"2025","unstructured":"Cao X, Mircea M, Cascione S, Amel A, Tsikari T, van den Hil FE, Mei H. Tissue microenvironment dictates the state of human iPSC-derived endothelial cells of distinct developmental origin in 3D cardiac microtissues. iScience, 2025, 28:","journal-title":"iScience"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nprot.2012.150","volume":"8","author":"Lian X","year":"2013","unstructured":"Lian X, Zhang J, Azarin SM, Zhu K, Hazeltine LB, Bao X, Hsiao C. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt\/\u03b2-catenin signaling under fully defined conditions. Nat Protoc, 2013, 8: 162-175.","journal-title":"Nat Protoc"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.stem.2020.06.001","volume":"27","author":"Buikema JW","year":"2020","unstructured":"Buikema JW, Lee S, Goodyer WR, Maas RG, Chirikian O, Li G, Miao Y. Wnt activation and reduced cell-cell contact synergistically induce massive expansion of functional human iPSC-derived cardiomyocytes. Cell Stem Cell, 2020, 27: 50-63.e5.","journal-title":"Cell Stem Cell"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/organoids5010009","volume":"5","author":"Xue Z","year":"2026","unstructured":"Xue Z, Yang R, Liu Y, Luo H. Organoid models: revolutionizing disease modeling and personalized therapeutics. Organoids, 2026, 5:","journal-title":"Organoids"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcvm.2025.1537730","volume":"12","author":"Yaqinuddin A","year":"2025","unstructured":"Yaqinuddin A, Jabri A, Mhannayeh A, Taftafa B, Alsharif M, Abbad T, Khan J. Cardiac organoids: a new tool for disease modeling and drug screening applications. Front Cardiovasc Med, 2025, 12: 1-8.","journal-title":"Front Cardiovasc Med"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.chembiol.2021.02.016","volume":"28","author":"Hnatiuk AP","year":"2021","unstructured":"Hnatiuk AP, Briganti F, Staudt DW, Mercola M. Human iPSC modeling of heart disease for drug development. Cell Chem Biol, 2021, 28: 271-282.","journal-title":"Cell Chem Biol"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1186\/s12967-025-06381-x","volume":"23","author":"Ni B","year":"2025","unstructured":"Ni B, Ye L, Zhang Y, Hu S, Lei W. Advances in humanoid organoid-based research on inter-organ communications during cardiac organogenesis and cardiovascular diseases. J Transl Med, 2025, 23:","journal-title":"J Transl Med"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"101396","DOI":"10.1016\/j.mtbio.2024.101396","volume":"30","author":"Li J","year":"2025","unstructured":"Li J, Li Y, Song G, Wang H, Zhang Q, Wang M, Zhao M. Revolutionizing cardiovascular research: human organoids as a Beacon of hope for understanding and treating cardiovascular diseases. Mater Today Bio, 2025, 30:","journal-title":"Mater Today Bio"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"1536843","DOI":"10.3389\/fbioe.2025.1536843","volume":"13","author":"Palam\u00e0 MEF","year":"2025","unstructured":"Palam\u00e0 MEF, Gorgun C, Rovere M, Shaw GM, Reverberi D, Formica M, Quarto E.  Batch variability and anti-inflammatory effects of iPSC-derived mesenchymal stromal cell extracellular vesicles in osteoarthritis in vitro model . Front Bioeng Biotechnol, 2025, 13:","journal-title":"Front Bioeng Biotechnol"},{"key":"CITATION28","doi-asserted-by":"crossref","unstructured":"Oliver GR, Domingues AM, Barnett CC. Batch effect correction in a functional colorectal cancer organoid clinical correlation study batch effect correction in a functional colorectal cancer organoid clinical correlation study.  Preprints  2026, doi:10.20944\/preprints202602.1067.v1 .","DOI":"10.64898\/2026.02.05.704065"},{"key":"CITATION29","doi-asserted-by":"crossref","unstructured":"Xue C, Sun F, Zhu H, Shi J, Wang J, Sun Q, Tong M, et al. Advancements, strategies, and challenges in organoid-based drug evaluation for tissue engineering and regenerative medicine.  Engineering  2026, 62: 34\u201350 .","DOI":"10.1016\/j.eng.2025.10.013"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"101560","DOI":"10.1016\/j.xpro.2022.101560","volume":"3","author":"Lyra-Leite DM","year":"2022","unstructured":"Lyra-Leite DM, Guti\u00e9rrez-Guti\u00e9rrez \u00d3, Wang M, Zhou Y, Cyganek L, Burridge PW. A review of protocols for human iPSC culture, cardiac differentiation, subtype-specification, maturation, and direct reprogramming. STAR Protocols, 2022, 3:","journal-title":"STAR Protocols"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"a035428","DOI":"10.1101\/cshperspect.a035428","volume":"12","author":"Gilbert G","year":"2020","unstructured":"Gilbert G, Demydenko K, Dries E, Puertas RD, Jin X, Sipido K, Roderick HL. Calcium signaling in cardiomyocyte function. Cold Spring Harb Perspect Biol, 2020, 12:","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"5587","DOI":"10.1016\/j.cell.2023.10.030","volume":"186","author":"Schmidt C","year":"2023","unstructured":"Schmidt C, Deyett A, Ilmer T, Haendeler S, Torres Caballero A, Novatchkova M, Netzer MA. Multi-chamber cardioids unravel human heart development and cardiac defects. Cell, 2023, 186: 5587-5605.","journal-title":"Cell"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1161\/CIRCRESAHA.114.303475","volume":"114","author":"Kaestner L","year":"2014","unstructured":"Kaestner L, Scholz A, Tian Q, Ruppenthal S, Tabellion W, Wiesen K, Katus HA.  Genetically encoded Ca2+ indicators in cardiac myocytes . Circ Res, 2014, 114: 1623-1639.","journal-title":"Circ Res"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.34133\/research.1165","volume":"9","author":"Liu C","year":"2026","unstructured":"Liu C, Guo J, Mirzayeva G, Spanos M, Teng R, Li G, Cretoiu D. 3D cardiac constructs in drug discovery: current advances and future challenges. Research, 2026, 9:","journal-title":"Research"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.cell.2017.03.050","volume":"169","author":"Hulsmans M","year":"2017","unstructured":"Hulsmans M, Clauss S, Xiao L, Aguirre AD, King KR, Hanley A, Hucker WJ. Macrophages facilitate electrical conduction in the heart. Cell, 2017, 169: 510-522.e20.","journal-title":"Cell"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"114302","DOI":"10.1016\/j.celrep.2024.114302","volume":"43","author":"Lock RI","year":"2024","unstructured":"Lock RI, Graney PL, Tavakol DN, Nash TR, Kim Y, Sanchez Jr. E, Morsink M. Macrophages enhance contractile force in iPSC-derived human engineered cardiac tissue. Cell Rep, 2024, 43:","journal-title":"Cell Rep"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"818188","DOI":"10.3389\/fcvm.2022.818188","volume":"9","author":"Hu S","year":"2022","unstructured":"Hu S, Yang M, Huang S, Zhong S, Zhang Q, Ding H, Xiong X. Different roles of resident and non-resident macrophages in cardiac fibrosis. Front Cardiovasc Med, 2022, 9:","journal-title":"Front Cardiovasc Med"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41590-018-0272-2","volume":"20","author":"Dick SA","year":"2019","unstructured":"Dick SA, Macklin JA, Nejat S, Momen A, Clemente-Casares X, Althagafi MG, Chen J. Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction. Nat Immunol, 2019, 20: 29-39.","journal-title":"Nat Immunol"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"110148","DOI":"10.1016\/j.bej.2026.110148","volume":"231","author":"Katsuda T","year":"2026","unstructured":"Katsuda T, Utami T, Gong Y, Tokito F, Kido T, Matsunaga K, Miyajima A. Synergy between oxygenation and co-culture with liver sinusoidal endothelial cells drives expansion of functional liver organoids. Biochem Eng J, 2026, 231:","journal-title":"Biochem Eng J"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fbioe.2021.634403","volume":"9","author":"Tse HM","year":"2021","unstructured":"Tse HM, Gardner G, Dominguez-Bendala J, Fraker CA. The importance of proper oxygenation in 3D culture. Front Bioeng Biotechnol, 2021, 9: 1-5.","journal-title":"Front Bioeng Biotechnol"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1002\/bit.28640","volume":"121","author":"Utami T","year":"2024","unstructured":"Utami T, Danoy M, Khadim RR, Tokito F, Arakawa H, Kato Y, Kido T. A highly efficient cell culture method using oxygen-permeable PDMS-based honeycomb microwells produces functional liver organoids from human induced pluripotent stem cell-derived carboxypeptidase M liver progenitor cells. Biotech Bioeng, 2024, 121: 1177-1189.","journal-title":"Biotech Bioeng"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"8156","DOI":"10.3390\/app15158156","volume":"15","author":"Zang L","year":"2025","unstructured":"Zang L, Kondo S, Komada Y, Nishimura N. Enhanced drug screening efficacy in zebrafish using a highly oxygen-permeable culture plate. Appl Sci, 2025, 15:","journal-title":"Appl Sci"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.bioactmat.2024.05.043","volume":"40","author":"Du X","year":"2024","unstructured":"Du X, Jia H, Chang Y, Zhao Y, Song J. Progress of organoid platform in cardiovascular research. Bioactive Mater, 2024, 40: 88-103.","journal-title":"Bioactive Mater"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s13287-021-02340-7","volume":"12","author":"Zhao D","year":"2021","unstructured":"Zhao D, Lei W, Hu S. Cardiac organoid\u2014a promising perspective of preclinical model. Stem Cell Res Ther, 2021, 12:","journal-title":"Stem Cell Res Ther"},{"key":"CITATION45","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s13287-022-03215-1","volume":"13","author":"Ho BX","year":"2022","unstructured":"Ho BX, Pang JKS, Chen Y, Loh YH, An O, Yang HH, Seshachalam VP. Robust generation of human-chambered cardiac organoids from pluripotent stem cells for improved modelling of cardiovascular diseases. Stem Cell Res Ther, 2022, 13:","journal-title":"Stem Cell Res Ther"},{"key":"CITATION46","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1038\/s41467-019-09831-5","volume":"10","author":"Zhang J","year":"2019","unstructured":"Zhang J, Tao R, Campbell KF, Carvalho JL, Ruiz EC, Kim GC, Schmuck EG. Functional cardiac fibroblasts derived from human pluripotent stem cells via second heart field progenitors. Nat Commun, 2019, 10:","journal-title":"Nat Commun"},{"key":"CITATION47","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1039\/D5LC00221D","volume":"25","author":"Balachander GM","year":"2025","unstructured":"Balachander GM, Ng IC, Pai RR, Mitra K, Tasnim F, Lim YS, Kwok R. LEADS\u2014a comprehensive human liver-on-a-chip for non-alcoholic steatohepatitis (NASH) drug testing. Lab Chip, 2025, 25: 3444-3466.","journal-title":"Lab Chip"},{"key":"CITATION48","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1093\/eurheartj\/ehs442","volume":"34","author":"Christophersen IE","year":"2013","unstructured":"Christophersen IE, Olesen MS, Liang B, Andersen MN, Larsen AP, Nielsen JB, Hauns\u00f8 S. Genetic variation in KCNA5: impact on the atrial-specific potassium current IKur in patients with lone atrial fibrillation. Eur Heart J, 2013, 34: 1517-1525.","journal-title":"Eur Heart J"},{"key":"CITATION49","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jmb.2006.03.066","volume":"359","author":"Grabarek Z","year":"2006","unstructured":"Grabarek Z. Structural basis for diversity of the EF-hand calcium-binding proteins. J Mol Biol, 2006, 359: 509-525.","journal-title":"J Mol Biol"},{"key":"CITATION50","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00424-021-02578-3","volume":"473","author":"Luo XL","year":"2021","unstructured":"Luo XL, Zhang P, Liu X, Huang S, Rao SL, Ding Q, Yang HT. Myosin light chain 2 marks differentiating ventricular cardiomyocytes derived from human embryonic stem cells. Pflugers Arch-Eur J Physiol, 2021, 473: 991-1007.","journal-title":"Pflugers Arch-Eur J Physiol"},{"key":"CITATION51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fbioe.2021.673212","volume":"9","author":"Chan AHP","year":"2021","unstructured":"Chan AHP, Huang NF. Engineering cardiovascular tissue chips for disease modeling and drug screening applications. Front Bioeng Biotechnol, 2021, 9: 1-7.","journal-title":"Front Bioeng Biotechnol"},{"key":"CITATION52","doi-asserted-by":"publisher","first-page":"5258","DOI":"10.1038\/s41598-020-58935-2","volume":"10","author":"Fletcher S","year":"2020","unstructured":"Fletcher S, Maddock H, James RS, Wallis R, Gharanei M.  The cardiac work-loop technique: an in vitro model for identifying and profiling drug-induced changes in inotropy using rat papillary muscles . Sci Rep, 2020, 10:","journal-title":"Sci Rep"},{"key":"CITATION53","doi-asserted-by":"publisher","first-page":"6289","DOI":"10.1038\/s41598-018-24676-6","volume":"8","author":"O\u2032Connor RS","year":"2018","unstructured":"O\u2032Connor RS, Guo L, Ghassemi S, Snyder NW, Worth AJ, Weng L, Kam Y. The CPT1a inhibitor, etomoxir induces severe oxidative stress at commonly used concentrations. Sci Rep, 2018, 8:","journal-title":"Sci Rep"},{"key":"CITATION54","doi-asserted-by":"publisher","first-page":"100095","DOI":"10.1016\/j.mocell.2024.100095","volume":"47","author":"Yoo I","year":"2024","unstructured":"Yoo I, Ahn I, Lee J, Lee N. Extracellular flux assay (Seahorse assay): diverse applications in metabolic research across biological disciplines. Molecules Cells, 2024, 47:","journal-title":"Molecules Cells"},{"key":"CITATION55","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ajps.2018.08.008","volume":"14","author":"Cao J","year":"2019","unstructured":"Cao J, Choi JS, Oshi MA, Lee J, Hasan N, Kim J, Yoo JW. Development of PLGA micro- and nanorods with high capacity of surface ligand conjugation for enhanced targeted delivery. Asian J Pharm Sci, 2019, 14: 86-94.","journal-title":"Asian J Pharm Sci"},{"key":"CITATION56","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.stem.2020.05.004","volume":"26","author":"Giacomelli E","year":"2020","unstructured":"Giacomelli E, Meraviglia V, Campostrini G, Cochrane A, Cao X, van Helden RWJ, Krotenberg Garcia A. Human-iPSC-derived cardiac stromal cells enhance maturation in 3D cardiac microtissues and reveal non-cardiomyocyte contributions to heart disease. Cell Stem Cell, 2020, 26: 862-879.e11.","journal-title":"Cell Stem Cell"},{"key":"CITATION57","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.jacl.2018.08.004","volume":"12","author":"Steffen BT","year":"2018","unstructured":"Steffen BT, Duprez D, Szklo M, Guan W, Tsai MY. Circulating oleic acid levels are related to greater risks of cardiovascular events and all-cause mortality: the multi-ethnic study of atherosclerosis. J Clin Lipidol, 2018, 12: 1404-1412.","journal-title":"J Clin Lipidol"},{"key":"CITATION58","doi-asserted-by":"publisher","first-page":"14515","DOI":"10.2147\/JIR.S530054","volume":"Volume 18","author":"Jiang H","year":"2025","unstructured":"Jiang H, Na C, Zhu Y, Bi Y, Yang R, Yang R, Yang H. Multiple roles of palmitic acid in cardiovascular diseases. J Inflamm Res, 2025, Volume 18: 14515-14533.","journal-title":"J Inflamm Res"},{"key":"CITATION59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1139\/cjpp-2025-0249","volume":"104","author":"Tappia PS","year":"2026","unstructured":"Tappia PS, Garriock E, Ramjiawan B, Moghadasian MH. High fructose consumption induces cardiac dysfunction and vascular abnormalities. Can J Physiol Pharmacol, 2026, 104: 1-10.","journal-title":"Can J Physiol Pharmacol"},{"key":"CITATION60","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3390\/cells10030629","volume":"10","author":"Guti\u00e9rrez-Cuevas J","year":"2021","unstructured":"Guti\u00e9rrez-Cuevas J, Sandoval-Rodriguez A, Meza-Rios A, Monroy-Ram\u00edrez HC, Galicia-Moreno M, Garc\u00eda-Ba\u00f1uelos J, Santos A. Molecular mechanisms of obesity-linked cardiac dysfunction: an up-date on current knowledge. Cells, 2021, 10:","journal-title":"Cells"},{"key":"CITATION61","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.3390\/ijms27062740","volume":"27","author":"Han Y","year":"2026","unstructured":"Han Y, Chen X, Fonseka O, Liu W. Lipotoxicity in diabetic cardiomyopathy: molecular basis and emerging therapeutic targets. Int J Mol Sci, 2026, 27:","journal-title":"Int J Mol Sci"},{"key":"CITATION62","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.3390\/ijms26073016","volume":"26","author":"Tashkandi AJ","year":"2025","unstructured":"Tashkandi AJ, Gorman A, McGoldrick Mathers E, Carney G, Yacoub A, Setyaningsih WAW, Kuburas R. Metabolic and mitochondrial dysregulations in diabetic cardiac complications. Int J Mol Sci, 2025, 26:","journal-title":"Int J Mol Sci"},{"key":"CITATION63","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.metabol.2012.02.013","volume":"61","author":"Mandavia CH","year":"2012","unstructured":"Mandavia CH, Pulakat L, DeMarco V, Sowers JR. Over-nutrition and metabolic cardiomyopathy. Metabolism, 2012, 61: 1205-1210.","journal-title":"Metabolism"},{"key":"CITATION64","doi-asserted-by":"publisher","first-page":"10742484231162248","DOI":"10.1177\/10742484231162249","volume":"28","author":"Wang X","year":"2023","unstructured":"Wang X, Xu Z, Chang R, Zeng C, Zhao Y. High-fructose diet induces cardiac dysfunction via macrophage recruitment in adult mice. J Cardiovasc Pharmacol Ther, 2023, 28:","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"CITATION65","doi-asserted-by":"publisher","first-page":"e008145","DOI":"10.1161\/JAHA.117.008145","volume":"7","author":"Kimura A","year":"2018","unstructured":"Kimura A, Ishida Y, Furuta M, Nosaka M, Kuninaka Y, Taruya A, Mukaida N. Protective roles of interferon-\u03b3 in cardiac hypertrophy induced by sustained pressure overload. J Am Heart Assoc, 2018, 7:","journal-title":"J Am Heart Assoc"},{"key":"CITATION66","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1161\/01.CIR.101.4.423","volume":"101","author":"Bartunek J","year":"2000","unstructured":"Bartunek J, Weinberg EO, Tajima M, Rohrbach S, Katz SE, Douglas PS, Lorell BH.  Chronic NG-nitro-L-arginine methyl ester-induced hypertension . Circulation, 2000, 101: 423-429.","journal-title":"Circulation"},{"key":"CITATION67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-76066-w","volume":"14","author":"Maluleke TT","year":"2024","unstructured":"Maluleke TT, Manilall A, Shezi N, Baijnath S, Millen AME. Acute exposure to LPS induces cardiac dysfunction via the activation of the NLRP3 inflammasome. Sci Rep, 2024, 14: 1-4.","journal-title":"Sci Rep"},{"key":"CITATION68","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cardiores.2006.10.002","volume":"74","author":"Bujak M","year":"2007","unstructured":"Bujak M, Frangogiannis NG. The role of TGF-\u03b2 signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res, 2007, 74: 184-195.","journal-title":"Cardiovasc Res"},{"key":"CITATION69","doi-asserted-by":"publisher","first-page":"e040320","DOI":"10.1161\/JAHA.124.040320","volume":"14","author":"Ohno J","year":"2025","unstructured":"Ohno J, Min KD, Sunayama I, Matsumoto Y, Daimon A, Manabe E, Oboshi M. Atrial natriuretic peptide at discharge as a predictive marker for early rehospitalization in patients with heart failure with preserved ejection fraction. J Am Heart Assoc, 2025, 14:","journal-title":"J Am Heart Assoc"},{"key":"CITATION70","doi-asserted-by":"publisher","first-page":"107863","DOI":"10.1016\/j.pharmthera.2021.107863","volume":"227","author":"Kuwahara K","year":"2021","unstructured":"Kuwahara K. The natriuretic peptide system in heart failure: diagnostic and therapeutic implications. Pharmacol Ther, 2021, 227:","journal-title":"Pharmacol Ther"},{"key":"CITATION71","unstructured":"Govindan, S. et al. Increase in cardiac myosin binding protein-C plasma levels is a sensitive and cardiac-specific biomarker of myocardial infarction.  Am. J. Cardiovasc. Dis  2013, 3: 60\u201370 ."},{"key":"CITATION72","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2217\/bmm.11.100","volume":"6","author":"Sadayappan S","year":"2012","unstructured":"Sadayappan S. Cardiac myosin binding protein-c: a potential early-stage, cardiac-specific biomarker of ischemia-reperfusion injury. Biomarkers Med, 2012, 6: 69-72.","journal-title":"Biomarkers Med"},{"key":"CITATION73","doi-asserted-by":"publisher","first-page":"101261","DOI":"10.1016\/j.redox.2019.101261","volume":"26","author":"Vir\u00e1g L","year":"2019","unstructured":"Vir\u00e1g L, Ja\u00e9n RI, Regdon Z, Bosc\u00e1 L, Prieto P. Self-defense of macrophages against oxidative injury: fighting for their own survival. Redox Biol, 2019, 26:","journal-title":"Redox Biol"},{"key":"CITATION74","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41392-025-02124-y","volume":"10","author":"Guan F","year":"2025","unstructured":"Guan F, Wang R, Yi Z, Luo P, Liu W, Xie Y, Liu Z. Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets. Sig Transduct Target Ther, 2025, 10:","journal-title":"Sig Transduct Target Ther"},{"key":"CITATION75","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.it.2023.10.004","volume":"44","author":"Rodr\u00edguez-Morales P","year":"2023","unstructured":"Rodr\u00edguez-Morales P, Franklin RA. Macrophage phenotypes and functions: resolving inflammation and restoring homeostasis. Trends Immunol, 2023, 44: 986-998.","journal-title":"Trends Immunol"},{"key":"CITATION76","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41467-019-08680-6","volume":"10","author":"Wang P","year":"2019","unstructured":"Wang P, Geng J, Gao J, Zhao H, Li J, Shi Y, Yang B. Macrophage achieves self-protection against oxidative stress-induced ageing through the Mst-Nrf2 axis. Nat Commun, 2019, 10:","journal-title":"Nat Commun"},{"key":"CITATION77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.57920","volume":"9","author":"Alonso-Herranz L","year":"2020","unstructured":"Alonso-Herranz L, Sah\u00fan-Espa\u00f1ol \u00c1, Paredes A, Gonzalo P, Gkontra P, N\u00fa\u00f1ez V, Clemente C. Macrophages promote endothelial-to-mesenchymal transition via MT1-MMP\/TGF\u03b21 after myocardial infarction. eLife, 2020, 9: 1-30.","journal-title":"eLife"},{"key":"CITATION78","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1161\/CIRCRESAHA.122.320305","volume":"130","author":"Thomas D","year":"2022","unstructured":"Thomas D, Choi S, Alamana C, Parker KK, Wu JC. Cellular and engineered organoids for cardiovascular models. Circ Res, 2022, 130: 1780-1802.","journal-title":"Circ Res"},{"key":"CITATION79","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.stem.2024.05.011","volume":"31","author":"Landau S","year":"2024","unstructured":"Landau S, Zhao Y, Hamidzada H, Kent GM, Okhovatian S, Lu RXZ, Liu C. Primitive macrophages enable long-term vascularization of human heart-on-a-chip platforms. Cell Stem Cell, 2024, 31: 1222-1238.e10.","journal-title":"Cell Stem Cell"},{"key":"CITATION80","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41392-025-02313-9","volume":"10","author":"Han X","year":"2025","unstructured":"Han X, Liao R, Li X, Zhang C, Huo S, Qin L, Xiong Y. Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies. Sig Transduct Target Ther, 2025, 10:","journal-title":"Sig Transduct Target Ther"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/3AC0B19204D24DC39310B84087182B55","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026152","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciengine.com\/sci-open\/api\/v1\/open\/file\/pdf\/3AC0B19204D24DC39310B84087182B55","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T08:26:42Z","timestamp":1789028802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciengine.com\/doi\/10.3724\/abbs.2026152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":80,"URL":"https:\/\/doi.org\/10.3724\/abbs.2026152","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,1]]}}}